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BMPER Mutation in Diaphanospondylodysostosis
Identified by Ancestral Autozygosity Mapping
and Targeted High-Throughput Sequencing
Vincent A. Funari,1,2,* Deborah Krakow,1,3,4,5 Lisette Nevarez,1 Zugen Chen,4 Tara L. Funari,1
Nithiwat Vatanavicharn,6 William R. Wilcox,1,2 David L. Rimoin,1,2,4,7 Stanley F. Nelson,2,4
and Daniel H. Cohn1,2,4,*
Diaphanospondylodysostosis (DSD) is a rare, recessively inherited, perinatal lethal skeletal disorder. The low frequency and perinatal
lethality of DSD makes assembling a large set of families for traditional linkage-based genetic approaches challenging. By searching
for evidence of unknown ancestral consanguinity, we identified two autozygous intervals, comprising 34 Mbps, unique to a single
case of DSD. Empirically testing for ancestral consanguinity was effective in localizing the causative variant, thereby reducing the
genomic space within which the mutation resides. High-throughput sequence analysis of exons captured from these intervals demon-
strated that the affected individual was homozygous for a null mutation in BMPER, which encodes the bone morphogenetic protein-
binding endothelial cell precursor-derived regulator. Mutations in BMPER were subsequently found in three additional DSD cases, con-
firming that defects in BMPER produce DSD. Phenotypic similarities between DSD and Bmper null mice indicate that BMPER-mediated
signaling plays an essential role in vertebral segmentation early in human development.Homozygosity mapping in consanguineous families can
be an efficient way to define loci for recessively inherited
disorders.1 In families with closely related parents, such
as first-cousinmatings, a large number of autozygous inter-
vals are typically found in their affected offspring,2 which
can make progress from locus to causative mutation diffi-
cult. Fewer and smaller intervals are predicted when the
parents have more distant familial relationships, but
knowledge of these relationships is frequently unknown.
However, detection of autozygosity in sporadic cases of
recessive disorders can be used to identify unknown
ancestral consanguinity, reflecting more distant genetic
relationships and thereby reducing the candidate intervals
in which the mutated gene is likely to be localized to
a more tractable size, simplifying the identification of the
causative mutations.
Diaphanospondylodysostosis (DSD, MIM 608022) is
a rare, recessively inherited, perinatal lethal skeletal
disorder.3–6 The primary skeletal characteristics of the
phenotype include a small chest, abnormal vertebral
segmentation, and posterior rib gaps containing incom-
pletely differentiated mesenchymal tissue.6 Consistent
craniofacial features include ocular hypertelorism, epican-
thal folds, a depressed nasal bridge with a short nose, and
low-set ears. The most commonly described extraskeletal
finding is nephroblastomatosis with cystic kidneys, but
other visceral findings have been described in some cases.3
The low frequency and perinatal lethality of DSD made
it impossible to assemble a set of families for linkage1Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90
University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA;
UCLA, Los Angeles, CA 90095, USA; 4Department of Human Genetics, Da
5Department of Obstetrics and Gynecology, David Geffen School of Medicine a
ment of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok 10700, Thail
Los Angeles, CA 90095, USA
*Correspondence: vincent.funari@cshs.org (V.A.F.), dan.cohn@cshs.org (D.H.C
DOI 10.1016/j.ajhg.2010.08.015. 2010 by The American Society of Human
532 The American Journal of Human Genetics 87, 532–537, Octoberstudies. We therefore tested four genetically independent
DSD cases for autozygosity with whole-genome SNP data.
All clinical data, radiographs, and tissue were obtained
through the International Skeletal Dysplasia Registry
(ISDR) and with informed consent under an institutional
review board-approved protocol. The SNP array genotyp-
ing and identity-by-descent (IBD) analysis were performed
as described in Tompson et al., 2008.7 Briefly, DNA was
processed and hybridized to GeneChip Human Mapping
250K arrays (NspI) as per manufacturer’s recommenda-
tions (Affymetrix). Genotypes were called with GeneChip
DNA analysis software (version 2.0, Affymetrix) and then
analyzed in Mathematica via a sliding-window approach
with a maximum of five errors allowed in 100 SNPs, as
described previously.7
In one case, ISDR reference number R05-062A (II-2 in
Figures 1A and 1B), there were three blocks of homozy-
gosity, each larger than 5 Mbps (Figure 1C), providing
strong evidence of a consanguineous mating. Homozy-
gosity for the same haplotype for one of these intervals,
on chromosome 6, was shared with an unaffected sibling
(II-1), leaving the two intervals on chromosomes 1 and 7
as candidate intervals uniquely associated with DSD. These
two regions together contained 34 Mbps, comprising 166
known genes (see Table S1 available online).
To determine whether one of the intervals contained a
DSD mutation, we employed a targeted capture-and-rese-
quencing approach for individual II-2. The genomic library
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Figure 1. Radiographic Phenotype and
Homozygosity Mapping in Diaphanospon-
dylodysostosis Family R05-062
(A) Pedigree of the family.
(B) Anteroposterior radiograph of indi-
vidual II-2. Note the abnormalities of the
ribs, including rib gaps, and the defects in
vertebral segmentation and ossification.
(C) Homozygositymapping in II-2 showing
the sizes of the blocks across the genome in
cM. The block on chromosome 6 was also
present in the unaffected sibling, II-2 (see
Table S1).protocol version 2.3, and the array-based targeting enrich-
ment protocol was performed with custom 244K microar-
rays (Agilent) via a protocol modified from Lee et al.,
2009.8 The arrays were designed to target every exon in
RefSeq in the autozygous intervals identified. Specifically,
the probes included all validated comparative genomic
hybridization probes for all exons in the intervals, at least
two probes were used for each exon, and there was 30 bp
spacing between adjacent probes. The hybridization of
the DNA library to the arrays and all washing steps were
performed as recommended in the Agilent CGH array
protocol. However, after hybridization, stripping was per-
formed with a low salt buffer at 5 above the hybridization
temperature. The eluted sample was then enriched by PCR,
and the hybridization-and-washing process was repeated
with the same array for further enrichment. The sample
was loaded onto one channel of an eight channel Illumina
GAIIx flow cell, and 75 bp paired-end sequencing was per-
formed. The image data were processed with the Genome
Analyzer Pipeline version 1.0, and six million sequences
derived from the captured exons were aligned to the
human reference genome, hg18 (University of California,
Santa Cruz), by Burrows-Wheeler Alignment. Variants were
further filtered, analyzed, and visualized with SAMtools9
and the UCSC Genome Browser (Figure 2).10 Single-nucle-
otide variants were selected for those observed in the
homozygous state in exons but not present in dbSNP130,
with a minimum coverage of four reads at the variant posi-
tion, and the variant call represented greater than 90% of
the reads (summarized in Table S2).
Four single-nucleotide variants that predicted homozy-
gosity for nonsynonymous amino acid changes, all in
genes in the interval on chromosome 7 and all of which
were not found in dbSNP build 130, were identified (Table
1). Among the variants was a c.925C>T point mutation inThe American Journal of Human Geexon 9 of BMPER (MIM 608699),
which encodes the bone morphoge-
netic protein-binding endothelial
cell precursor-derived regulator, pre-
dicting homozygosity for a p.Q309X
null mutation (Figure 1D). Amplifica-
tion and Sanger sequence analysis of
exon 9 in the proband confirmed
the mutation (Figure 1D), and bothparents and the unaffected sibling were carriers of the
change (data not shown).
To determine whether BMPERmutations were present in
other DSD cases, we carried out mutation analysis of the
15 coding exons and flanking splice junctions in three
genetically independent cases (Table 2). The 15 coding
exons and flanking splice junctions of BMPER were ampli-
fied with the QIAGEN HotStart Hifidelity kit and primers
that were designed with Primer3 (Table S3). Sequences of
the PCR products were determined with the same amplifi-
cation primers. Mutations are described relative to the
BMPER cDNA (NM_133468.3), and protein sequence was
numbered according to the first nucleotide of the transla-
tion start codon or the first amino acid, respectively.
In case R06-244A, compound heterozygosity for a
paternally derived complex insertion-deletion mutation,
c.26_35delCTCTGGCTGAinsAGACCAGAGCGGCG, pre-
dicted to result in a frameshift (p.Ala9GlufsX44), was
found in exon 1. The second mutation was maternally
derived (c.1031þ5G>A) and altered the consensus splice
donor at the þ5 position of intron 11. Patient cells or
tissues expressing BMPER were not available, but the skip-
ping of exon 11 would be predicted to lead to an in-frame
deletion of 35 codons and delete much of the fifth chor-
din-like cysteine-rich domain, which is important for
binding to BMPER-regulated bonemorphogenetic proteins
(BMPs).11,12 Retention of intron 11 would be predicted to
lead to a null allele. This allele was absent from dbSNP
build 130 and was not identified in 210 alleles derived
from individuals in the same ethnic group, indicating
that it is not a frequent polymorphism in the population
(data not shown). In case R83-044A, a point mutation
(c.514C>T) in exon 6 predicting a p.Q172X change was
found. The secondmutation was not identified, suggesting
that the other allele either results in a deletion or does notnetics 87, 532–537, October 8, 2010 533
Figure 2. Molecular Basis of Diaphanospondylodysostosis
(A) The genomic structure and sequencing coverage for exon 9 of BMPER is shown, with the exon shown in yellow and the introns in
blue (the specificity of capture for a larger region of BMPER is shown in Figure S1). Forward and reverse reads derived from the Solexa
sequences are illustrated in purple and gray, respectively. The RefSeq BMPER amino acid sequence translation is directly under the refer-
ence nucleotide sequence, and the location of the variant identified is indicated by the red line.
(B) The zoomed panel of the region boxed in (A) shows the consensus of the Solexa sequence reads at each nucleotide position and the
corresponding amino acid translation for individual II-2 below the reference sequence. Homozygosity for the pathological sequence
change c.925C>T, which results in the p.Q309X premature termination codon, is shown.
(C) Confirmation of the mutation by Sanger sequence analysis of a PCR-amplified fragment containing exon 9 from II-2.reside within the coding region. For case R94-127A,
compound heterozygosity for a c.1638T>A mutation in
exon 13, predicted to result in a p.C546X nonsense muta-
tion, and a c.1109C>T point mutation, predicted to lead to
a p.P370L missense substitution in exon 12, were found.
The proline is evolutionarily conserved among 28 different
vertebrates, from primates to fish, and is in the conserved
von Willebrand factor type D domain of the protein. The
mutation was not found among 216 alleles from an ethni-
cally matched control panel, indicating that it is not
a frequent polymorphism in the population (data not
shown). Thus, all three patients carried mutations in
BMPER, demonstrating that mutations in BMPER cause
DSD. Furthermore, because four of the six mutations are
predicted to lead to premature termination codons, we
conclude that absent or markedly diminished BMPER
activity produces DSD.
Recently, a number of genes associated with recessive
disorders have been identified by high-throughput
sequence analysis in regions of linkage identified by homo-
zygosity/autozygosity mapping in large extended consan-534 The American Journal of Human Genetics 87, 532–537, Octoberguineous families13 and by overlapping regions of auto-
zygosity in sets of smaller consanguineous families.14 In
some instances, whole-genome15 or exome16,17 sequence
analysis has been used. Here we show that empirically
testing for autozygosity that reflects unknown ancestral
consanguinity combined with high-throughput sequence
analysis of the genes in the autozygous region or regions
is another way to localize and identify the loci in recessive
disorders of unknown etiology.
For DSD, the parents of the proband in whom auto-
zygosity was detected originated in the state of Sinaloa,
Mexico. One parent was from the city of Mazatlan, and
the other was from a village 195 km away. The parents
were unable to identify a common relative, suggesting
that there may be additional carriers for the DSDmutation
in this region of Mexico. These data are similar to instances
of unknown consanguinity in Mexican families with
spondyloepimetaphyseal dysplasia aggrecan type (MIM
612813)7 and recessive osteogenesis imperfecta type III
(MIM 259420).18 Furthermore, a recent study identified
excess homozygosity among Latinos, including many8, 2010
Table 1. SNPs Found in the Homozygous State by Targeted
Resequencing that Were Not Identified in dbSNP130 and Predict
Nonsynonymous Amino Acid Changes
Chromosome Gene Exon Coverage
DNA
Sequence
Change
Amino
Acid Change
7 BMPER 9 25 C>T p.Q309X
7 ELMO1 12 8 A>C p.I362S
7 ABCA13 15 17 G>C p.K886N
7 PKD1L1 17 24 C>T p.V906Iindividuals of Mexican descent, who recently moved to
the United States.19 Also, an increased number of long
regions of homozygosity has been observed in a set of
samples derived from Guadalajara, Mexico, relative to
European and Asian populations,20 further supporting
the inference that ancestral consanguinity may be
common in the Mexican population. Thus, although
a higher frequency of recessive disorders is observed in
regions of the world where known consanguineous
matings are culturally favored, identifying autozygosity
because of unknown ancestral consanguinity by genotyp-
ing cases derived from other parts of the world, including
Mexico, may be advantageous. For DSD, detection of auto-
zygosity in a single sporadic case significantly reduced the
candidate genomic intervals likely to harbor the mutated
gene, an enrichment that facilitated the targeted sequence
analysis that led to identification of the causal mutation.
DSD phenocopies many of the abnormalities found in
the Bmper (also known as Cv2) knockout mouse,21–23
further supporting the BMPER sequence changes as the
disease-causing mutations. The characteristic features of
the human phenotype, perinatal death due to respiratory
insufficiency, craniofacial abnormalities, lack of vertebral
ossification, rib gaps, and renal abnormalities were recapit-
ulated in the mouse model. Many of the phenotypic
abnormalities seen in both species appear to result from
an early developmental abnormality in mesenchymal
differentiation that is necessary for proper maturation ofTable 2. Mutations Identified in Four Patients with
Diaphanospondylodysostosis
Patient Location Mutation Result
R05-062A Exon 9 c.925C>T p.Q309X
Exon 9 c.925C>T p.Q309X
R06-244A Exon 1 c.26_35delCTCTGGCTGA
insAGACCAGAGCGGCG
p.Ala9GlufsX44
Intron 11 c.1031þ5G>A Unknown
R83-044A Exon 6 c.514C>T p.Q172X
Unknown Unknown Unknown
R94-127A Exon 12 c.1109C>T p.P370L
Exon 13 c.1638T>A p.C546X
The Americthe vertebrae, kidney, and other tissues,21–23 confirming
the importance of BMP signaling in these processes.
BMPs are members of the TGF-b superfamily, play
a pivotal role in the signaling networks in many organs
and tissues, and are required for normal skeletal morpho-
genesis.24 BMP pathways have been linked to regulating
cell proliferation, apoptosis, differentiation, and morpho-
genesis.25 Bmper is a paralog of chordin and kielin forming
a family of molecules, which has been thought to function
as BMP antagonists by binding BMPs to limit their activi-
ties.26 However, recent data suggest that BMPER has both
antagonistic and agonistic mechanisms of action on BMP
signaling,27 with the relative concentrations of BMPER
and its ligands determining whether Bmper has a pro- or
anti-BMP signaling role.21–23,27 Abnormalities in vertebral
development in the Bmper knockoutmice share similarities
with Bmp428 and Bmp729 knockout mice, models of defi-
cient BMP signaling, thus supporting a predominantly
pro-BMP role in vivo for BMPER in skeletal development.
In the Bmper knockout mice, the defects in the vertebrae
are enhanced by a Bmp4 null allele21 and the kidney abnor-
malities are enhanced by absence of Bmp7,22 further sug-
gesting that BMPER plays a pro-BMP role in these contexts.
Similarly, absence of BMPER leads to reduced SMAD1
phosphorylation during vertebral and nephrogenic devel-
opment,22,23 again suggesting that decreased BMP signal-
ing results in the developmental defects observed in the
mouse. Although the precise effects on BMP signaling
that produce DSD in humans have not yet been character-
ized, it is likely that absence of BMPER disrupts the tight
regulation of BMP signaling that governs development of
the skeleton and other organs.30
Defects in vertebral segmentation, althoughmorpholog-
ically distinct from those observed in DSD, have been asso-
ciated with defects in components of the Notch signaling
pathway, including DLL3 (MIM 602768), LNFG (MIM
602576), MESP2 (MIM 605195), and HES7 (MIM
608059).31–33 In the Bmper null mice, Pax1, an early marker
of vertebral development, was normally expressed,21 indi-
cating that Bmper functions downstream of the early
stages of vertebral segmentation. The temporospatial rela-
tionship between the defect in Bmper and the Notch
pathway is uncharacterized.
In summary, this study used empiric identification of
autozygosity due to ancestral consanguinity in an auto-
somal-recessive disease to significantly refine candidate
intervals containing the mutated gene and thus the
genomic regions for targeted resequencing with a next-
generation sequencing platform. Using this approach, we
identified mutations in BMPER as the cause for diaphano-
spondylodysostosis and thus a requirement for BMPER-
mediated signaling in human vertebral development.Supplemental Data
Supplemental Data include one figure and three tables and can be
found with this article online at http://www.cell.com/AJHG/.an Journal of Human Genetics 87, 532–537, October 8, 2010 535
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